Definition/General

Introduction:
-Umbilical cord hemangioma is a rare benign vascular tumor occurring in 1 in 5,500 deliveries
-It represents the most common primary tumor of the umbilical cord
-The lesion consists of proliferating endothelial cells and capillary channels
-It may cause significant perinatal complications including fetal death.
Origin:
-Originates from abnormal angiogenesis within umbilical cord vessels
-Results from endothelial proliferation and capillary formation
-May arise from hypoxic stimulation or vascular injury
-Hamartomatous rather than truly neoplastic
-Associated with altered blood flow patterns.
Classification:
-Classified as capillary hemangioma (most common) or cavernous hemangioma
-Small lesions (<2 cm) versus large lesions (>2 cm)
-Localized versus diffuse involvement
-May be associated with angiomatosis.
Epidemiology:
-Incidence: 1 in 5,500 deliveries
-No gender predilection
-No specific maternal age association
-Higher mortality with larger lesions
-Associated with polyhydramnios in 30% cases.

Clinical Features

Presentation:
-Polyhydramnios (30-70% cases)
-Preterm delivery (60% cases)
-Fetal heart failure
-Intrauterine fetal death (10-20%)
-Non-immune hydrops fetalis
-Cord compression effects.
Symptoms:
-Fetal distress during monitoring
-Abnormal cardiotocography patterns
-Decreased fetal movements
-Signs of fetal anemia
-Congestive heart failure in fetus
-Emergency delivery indication.
Risk Factors:
-Advanced maternal age
-Previous pregnancy losses
-Maternal diabetes
-Multiple pregnancy
-Vascular malformation syndromes
-Family history of hemangiomas.
Screening:
-Ultrasound examination may detect larger lesions
-Color Doppler shows increased vascularity
-Fetal echocardiography for heart failure
-Amniotic fluid assessment
-Serial monitoring recommended.

Master Cord Hemangioma Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Well-circumscribed mass within umbilical cord
-Red to purple color
-Soft, spongy texture
-Size ranges from 1-10 cm
-May cause focal cord enlargement.
Characteristics:
-Vascular channels visible on cut surface
-Hemorrhage may be present
-Thrombosis in some vessels
-Surrounding Wharton's jelly compressed
-Surface may be ulcerated.
Size Location:
-Size: typically 2-5 cm diameter
-Location: any segment of cord
-Fetal end more common
-May involve entire cord circumference
-Cord length usually normal.
Multifocality:
-Usually solitary lesion
-Multiple lesions rare
-May be associated with placental hemangiomas
-Angiomatosis pattern possible.

Microscopic Description

Histological Features:
-Proliferation of capillary-sized vessels and endothelial cells
-Well-formed vascular channels
-Endothelial cell lining intact
-Pericytes and smooth muscle present
-Surrounding Wharton's jelly compressed.
Cellular Characteristics:
-Plump endothelial cells without atypia
-Mitotic activity variable
-Pericytes surrounding vessels
-Smooth muscle cells in vessel walls
-Fibroblasts in stroma.
Architectural Patterns:
-Capillary hemangioma pattern most common
-Lobular arrangement of vessels
-Cavernous spaces may be present
-Thrombosis and fibrosis possible
-Hemosiderin deposits common.
Grading Criteria:
-Classification by vessel size and pattern
-Cellular proliferation assessment
-Mitotic count evaluation
-Thrombosis and fibrosis extent
-Size measurement important.

Immunohistochemistry

Positive Markers:
-CD31 highlights endothelial cells
-CD34 positive in vessels
-Factor VIII related antigen positive
-GLUT-1 may be positive
-Smooth muscle actin in pericytes.
Negative Markers:
-Cytokeratin negative in endothelium
-EMA typically negative
-S-100 negative
-Desmin negative in endothelium
-Lymphoid markers negative.
Diagnostic Utility:
-Confirms vascular nature of lesion
-Distinguishes from other tumors
-Excludes malignancy
-Identifies endothelial proliferation
-Differential diagnosis aid.
Molecular Subtypes:
-No specific molecular subtypes
-Infantile hemangioma markers may be present
-GLUT-1 positivity variable
-Vascular proliferation markers elevated.

Molecular/Genetic

Genetic Mutations:
-No specific genetic mutations identified
-Angiogenesis pathway alterations possible
-VEGF overexpression may be present
-Endothelial growth factor abnormalities
-Vascular development gene variants.
Molecular Markers:
-VEGF and receptors upregulated
-Angiopoietin signaling involved
-Endothelial proliferation markers elevated
-Hypoxia-inducible factors may be active.
Prognostic Significance:
-Size correlates with complications
-Large lesions (>4 cm) high risk
-Associated with fetal mortality
-Polyhydramnios increases risk
-Heart failure poor prognostic sign.
Therapeutic Targets:
-No specific therapeutic targets
-Early delivery may be indicated
-Fetal monitoring essential
-Antiangiogenic therapy research
-Corticosteroids investigational.

Differential Diagnosis

Similar Entities:
-Arteriovenous malformation
-Cord hematoma
-Teratoma
-Myxoma
-Angiosarcoma (rare).
Distinguishing Features:
-Hemangioma: benign vascular proliferation
-Hemangioma: no atypia
-AVM: abnormal connections
-Hematoma: blood products
-Teratoma: mixed tissue types
-Angiosarcoma: malignant features.
Diagnostic Challenges:
-Distinguishing from vascular malformations
-Size assessment significance
-Thrombosed vessels recognition
-Clinical correlation importance
-Sampling adequacy.
Rare Variants:
-Cavernous hemangioma
-Epithelioid hemangioma
-Sclerosing hemangioma
-Hemangioma with extensive thrombosis
-Multiple hemangiomas.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

Umbilical cord with focal mass measuring [X] cm

Tumor Description

Mass: [size] cm, [location], [color], [consistency]

Microscopic Pattern

Pattern: [capillary/cavernous] hemangioma with [degree] of vascular proliferation

Endothelial Features

Endothelial cells: [normal/plump], [present/absent] atypia, mitoses [count]/10 HPF

Associated Findings

Associated findings: [present/absent] thrombosis, [present/absent] fibrosis

Immunohistochemistry

IHC: CD31 [positive/negative], CD34 [positive/negative], confirming vascular nature

Clinical Significance

Clinical significance: [risk level] for fetal complications based on size [X] cm

Final Diagnosis

Umbilical cord hemangioma, [size] cm